Want to see AU:NGS full AI Analyst Report?
NGS Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.03
Previous CloseN/A
Volume2.65K
Average Volume (3M)283.41K
Market Cap
AU$7.33M
Enterprise ValueAU$2.27M
Total Cash (Recent Filing)AU$517.35K
Total Debt (Recent Filing)AU$504.34K
Price to Earnings (P/E)―
Beta-8.57
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.07
Shares Outstanding333,093,200
10 Day Avg. Volume24,410
30 Day Avg. Volume283,411
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.10
Price to Sales (P/S)0.01
P/FCF Ratio-0.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Equity RecoveryThe shift to positive shareholders' equity in 2025 provides a meaningful structural improvement to solvency and creditor confidence. This recovery reduces immediate insolvency risk, improves ability to raise incremental capital on better terms, and gives management a firmer capital buffer for 2–6 month operational planning.
Asset Base GrowthAn increase in total assets suggests the company has invested or retained resources that can support revenue-generating activities or restructuring. Persisting asset growth can underpin capacity expansion or collateral for funding, creating optionality for strategic initiatives over the medium term.
Lean Cost StructureA very small employee base points to a lean operating model that can limit fixed-cost burn and allow rapid reallocation of resources. Over 2–6 months this structural low overhead can extend runway, enabling management to prioritize product-market fit or targeted marketing without large payroll drag.
Bears Say
Shrinking RevenueSustained revenue decline is a core structural weakness: it reduces operating leverage, shrinks addressable opportunity, and undermines the economics of any fixed-cost base. Over months this trend limits the company's ability to scale, makes cost recovery harder, and increases dependence on financing to cover routine operations.
Margin Compression & LossesSharp gross margin deterioration and persistently large net losses signal structural profitability gaps—poor pricing, cost inflation, or mix shifts. Unless product economics improve, margins will constrain path to breakeven, erode retained capital, and necessitate operational restructuring or new higher-margin revenue streams.
Weak Cash GenerationConsistent negative operating cash flow is a durable constraint: it drains reserves and forces reliance on external funding or balance-sheet moves. Over the medium term this raises refinancing and dilution risk, limits investment in growth, and makes the company vulnerable if capital markets or lenders tighten.
Nutritional Growth Solutions Ltd. News
NGS FAQ
What was Nutritional Growth Solutions Ltd.’s price range in the past 12 months?
Nutritional Growth Solutions Ltd. lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is Nutritional Growth Solutions Ltd.’s market cap?
Nutritional Growth Solutions Ltd.’s market cap is AU$7.33M.
When is Nutritional Growth Solutions Ltd.’s upcoming earnings report date?
Nutritional Growth Solutions Ltd.’s upcoming earnings report date is Aug 28, 2026 which is in 43 days.
How were Nutritional Growth Solutions Ltd.’s earnings last quarter?
Nutritional Growth Solutions Ltd. released its earnings results on Feb 27, 2026. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is Nutritional Growth Solutions Ltd. overvalued?
According to Wall Street analysts Nutritional Growth Solutions Ltd.’s price is currently Overvalued.
Does Nutritional Growth Solutions Ltd. pay dividends?
Nutritional Growth Solutions Ltd. does not currently pay dividends.
What is Nutritional Growth Solutions Ltd.’s EPS estimate?
Nutritional Growth Solutions Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nutritional Growth Solutions Ltd. have?
Nutritional Growth Solutions Ltd. has 333,093,200 shares outstanding.
What happened to Nutritional Growth Solutions Ltd.’s price movement after its last earnings report?
Nutritional Growth Solutions Ltd. reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nutritional Growth Solutions Ltd.?
Currently, no hedge funds are holding shares in AU:NGS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nutritional Growth Solutions Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:NGS Sentiment 100%
Sector Average 63%
Sector Average 63%
Insider Transactions
Bought Shares
Worth AU$410.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.44%
12-Months-Change
Fundamentals
Return on Equity
226.76%
Trailing 12-Months
Asset Growth
133.62%
Trailing 12-Months
Company Description
Nutritional Growth Solutions Ltd.
Headquartered in Tel Aviv, Israel, Nutritional Growth Solutions Ltd. is an enterprise focused on developing, producing, and marketing protein supplements specifically tailored for pediatric use. These products reach consumers both domestically and internationally, notably within the United States, under the recognized brand labels of Horlicks, Healthy Height, and Pro Up. The firm, established in 2013, underwent a name change in June 2020, transitioning from its former identity as N. G. Solutions Ltd. to its current designation.
Technical Analysis
Noumi Limited
―
Australian Dairy Nutritionals Group
―
Bioxyne Limited
―
Bubs Australia Ltd.
―
Nuchev Pty Ltd
―